Targeting mulitple dyslipidemias with fixed combinations – focus on extended release niacin and simvastatin

Dyslipidemia is a major risk factor in the initiation and progression of cardiovascular diseases such as atherosclerosis. Several pharmacological agents have been developed over the past 50 years which target various lipid components such as low density lipoprotein (LDL) cholesterol, triglyceride, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandian, Anbu, Arora, Anjali, Sperling, Laurence S, Khan, Bobby V
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605342/
https://www.ncbi.nlm.nih.gov/pubmed/19183748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605342/
https://www.ncbi.nlm.nih.gov/pubmed/19183748

Ejemplares similares